Ajax Therapeutics has completed a $95 million financing, with plans to advance lead candidate AJ1‑11095 for myelofibrosis ...

Sartorius plans to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery and in predictive ...

“A proinflammatory intestinal environment coincided with expansion, increased circulation, and migration of TNF-producing ...

The use of artificial intelligence (AI) has been increasing in scientific research and clinical applications. From ...

Single Technologies has developed a confocal-based optical system to sequence a 3D matrix for hugely parallel reactions in ...

A new study shows some brain cells age faster than others in Alzheimer's cases, and there are sex-specific differences in the ...

Discovery of SLFN11 as the strongest biomarker for chemotherapy responsiveness suggests relevance for ribosomal stalling in ...

A developer of pluripotent stem cell therapies has trademarked their approach to cost-effective therapy development.

Circe Biosciences entered into an exclusive worldwide licensing agreement arranged by Harvard's Office of Technology ...

Frédéric Revah, PhD, speaks with GEN's managing editor Corinna Singleman, PhD, about Généthon's past and future work in rare ...

Teesside University scientists are working with counterparts from the University of Leeds and three industry partners to ...

David Liu, PhD, devoted a few slides summarizing the clinical progress of base and prime editing platforms in diseases as ...